Global Tax Intern
AstraZeneca
Summary
Alexion-AstraZeneca Rare Disease is seeking undergraduate rising Juniors and Seniors majoring in Tax, Accounting, or a related field for a 10-week internship role at our site in New Haven, CT from June 07, 2027 to August 13, 2027.
Job description
Tax Planning & Administration
- Conduct basic US federal and state tax research as requested using RIA Checkpoint on issues impacting the company
- Provide support on corporate tax projects and initiatives.
- Assist with drafting tax transactions related to legal documents.
- Documenting the changes to the tax structure as a result of acquisitions and other transactions.
- Complete special projects as assigned.
Tax Compliance
- Assist in the coordination of the data gathering of the information needed to prepare the Company's tax returns.
- Engage with Global Tax Master Service Provider on various aspects of global tax compliance.
- Support in gathering information and supporting State income and franchise tax audits.
- Assist with arranging information and drafting documentation for Transfer Pricing reports.
Requirements
- Rising Junior and Rising Senior students majoring in Tax, Accounting, or a related field.
- Strong computer skills and functionality with the Microsoft Office 365 suite of products.
- Attention to detail and accuracy, with an ability to handle multiple assignments and to work independently for periods of time.
- Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design.
- Candidates must have an expected graduation date after August 2027.
- US Work Authorization is required at time of application.
- This role will not be granting CPT support.
- Ability to report onsite to New Haven, CT site 3-5 days per week.
- This role will not provide relocation assistance.
Benefits
- Hourly range $31-$32.50
- No relocation assistance
- No CPT support
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.